
3.15BUSD
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US98887Q1040
CUSIP
98887Q104
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
5.01
Dividend Share
-
Dividend Yield
-
Earnings Share
-1.8
Wall Street Target Price
34.13
EPS Estimate Current Year
-1.88
EPS Estimate Next Year
-1.98
EPS Estimate Current Quarter
-0.5918
EPS Estimate Next Quarter
-0.6372
Most Recent Quarter
-
Revenue TTM
441,727,008
Gross Profit TTM
2,794,000
EBITDA
-261,814,000
Profit Margin
-44.91%
Return On Assets TTM
-15.93%
Return On Equity TTM
-29.99%
Revenue Per Share TTM
3.964
Qtly Revenue Growth YOY
-6.80%
Diluted Eps TTM
-1.8
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
7.5262
Price Book MRQ
5.9021
Enterprise Value Revenue
6
Enterprise Value EBITDA
-2
34.61
0.46%962.60
0.42%977.55
0.26%900.30
0.00%136.78
0.00%314.48
-4.39%415.70
-2.10%162.45
-1.71%245.83
-0.99%547.20
-0.05%